Internal Medicine, Clinical Cardiatric Electrophysiology · Newport Beach, CA
NPI
1043425036
Since 2007
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
520 Superior Ave, Suite 330
Newport Beach, CA, 92663
Phone (949) 478-7373
Groups this clinician bills Medicare through
Medicare paid, 2024
$638K
7,418 services
Medicare patients, 2024
933
Average age 78
Drug cost, 2024
$1.0M
2,394 prescriptions
Company payments, 2025
$41K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajesh S Banker was code 93297 (external electrocardiographic monitoring), 776 times for 96 patients. In total Rajesh S Banker billed 7,418 services in 93 codes, and Medicare paid $638K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93297 External Electrocardiographic Monitoring | Office | 776 | 96 | $20.48 | $16K |
| 93298 External Electrocardiographic Monitoring | Office | 639 | 71 | $20.41 | $13K |
| 99214 Office E&M - Established | Office | 634 | 456 | $103.92 | $66K |
| 93000 Electrocardiogram | Office | 502 | 356 | $11.74 | $5,895 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 344 | 85 | $4.81 | $1,653 |
| 99454 E&M - Miscellaneous | Office | 341 | 64 | $40.37 | $14K |
| 99457 E&M - Miscellaneous | Office | 324 | 65 | $39.41 | $13K |
| 93306 Echocardiography (TTE/TEE) | Office | 241 | 212 | $165.18 | $40K |
| 93294 External Electrocardiographic Monitoring | Office | 232 | 68 | $23.49 | $5,450 |
| 93010 Electrocardiogram | Facility | 230 | 225 | $5.99 | $1,378 |
| 93295 External Electrocardiographic Monitoring | Office | 229 | 72 | $29.55 | $6,768 |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 220 | 107 | $76.22 | $17K |
| 93280 External Electrocardiographic Monitoring | Office | 155 | 102 | $30.10 | $4,666 |
| 93228 Electrocardiogram | Office | 150 | 130 | $20.71 | $3,107 |
| 99204 Office E&M - New | Office | 143 | 143 | $131.43 | $19K |
By year: 2022 $667K for 6,554 services; 2023 $500K for 6,479 services; 2024 $638K for 7,418 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajesh S Banker prescribed most often to Medicare patients was Eliquis (Apixaban), with 498 prescriptions and refills. In total Rajesh S Banker wrote 2,394 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 498 | 1,202 | 159 | $686K |
| Metoprolol Succinate Generic | 219 | 638 | 77 | $3,685 |
| Atorvastatin Calcium Generic | 124 | 371 | 43 | $1,666 |
| Xarelto Rivaroxaban | 121 | 274 | 38 | $148K |
| Sotalol Af Sotalol Hcl | 106 | 310 | 40 | $2,471 |
| Carvedilol Generic | 86 | 256 | 31 | $636 |
| Lisinopril Generic | 82 | 243 | 26 | $762 |
| Amlodipine Besylate Generic | 79 | 235 | 28 | $470 |
| Sotalol Sotalol Hcl | 76 | 207 | 32 | $1,721 |
| Amiodarone Hcl Generic | 68 | 191 | 29 | $4,492 |
| Furosemide Generic | 56 | 152 | 22 | $204 |
| Losartan Potassium Generic | 50 | 150 | 20 | $332 |
| Farxiga Dapagliflozin Propanediol | 48 | 105 | 14 | $59K |
| Rosuvastatin Calcium Generic | 46 | 130 | 20 | $995 |
| Flecainide Acetate Generic | 45 | 120 | 20 | $2,312 |
Brand drugs: - claims; generic drugs: 1,602 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rajesh S Banker $41K ($41K in general payments such as food, travel and fees) from 25 companies. The largest payer was Biosense Webster, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Biosense Webster, Inc. JNJ | 87 | $23K |
| Abbott Laboratories ABT | 37 | $16K |
| Boston Scientific Corporation BSX | 16 | $473 |
| Medtronic, Inc. MDT | 14 | $184 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $142 |
| Cardiva Medical, Inc. | 4 | $101 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $96.41 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $94.81 |
| Merck Sharp & Dohme LLC MRK | 5 | $94.43 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $85.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.